Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Class III drug recalls - low risk

Class III means the product is unlikely to cause harm but violates FDA labeling or manufacturing rules. These are the recalls you rarely hear about; pharmacies usually just swap the affected lot.

1,716 recalls, newest first.

Class III · Low risk

Endometrin

Discoloration; due to prolonged heat exposure.

Terminated Failed specification Ferring Pharmaceuticals Inc NDC 55566-6500-3 D-1426-2014
Class III · Low risk

Venlafaxine

Failed Dissolution Specification:12 hour time point at 18 months of product shelf life.

Terminated Dissolution failure Osmotica Pharmaceutical Corp NDC 0131-3268-32 D-1067-2013
Class III · Low risk

Loratadine 24 HR-OTC

Failed Tablet/Capsule Specifications: Affected lot numbers may contain chipped or broken tablets.

Terminated Failed specification Physicians Total Care, Inc. NDC 54868-5268-00 D-0239-2015
Class III · Low risk

Timolol Maleate Sterile Ophthalmic Solution

Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

Terminated Packaging defect PACK Pharmaceuticals, LLC NDC 16571-141-10 D-1073-2014
Class III · Low risk

Timolol Maleate Sterile Ophthalmic Solution

Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

Terminated Packaging defect PACK Pharmaceuticals, LLC NDC 16571-141-50 D-1072-2014
Class III · Low risk

Timolol Maleate Sterile Ophthalmic Solution

Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

Terminated Packaging defect PACK Pharmaceuticals, LLC NDC 16571-140-10 D-1071-2014
Class III · Low risk

Timolol Maleate Sterile Ophthalmic Solution

Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

Terminated Packaging defect PACK Pharmaceuticals, LLC NDC 16571-140-50 D-1070-2014
Class III · Low risk

Ofloxacin Ophthalmic Solution

Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

Terminated Packaging defect PACK Pharmaceuticals, LLC NDC 16571-130-11 D-1069-2014
Class III · Low risk

Ofloxacin Ophthalmic Solution

Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

Terminated Packaging defect PACK Pharmaceuticals, LLC NDC 16571-130-50 D-1068-2014
Class III · Low risk

Derma-Smoothe/FS

Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.

Terminated Wrong potency / content Hill Dermaceuticals, Inc. NDC 28105-150-04 D-008-2014
Class III · Low risk

Derma-Smoothe/FS

Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.

Terminated Wrong potency / content Hill Dermaceuticals, Inc. NDC 28105-149-04 D-007-2014
Class III · Low risk

Loratadine

Failed Tablet/Capsule Specifications: The products are being recalled due to chipped and broken tablets.

Terminated Failed specification Novartis Consumer Health D-022-2014
Class III · Low risk

Hydrocodone Bitartrate and Acetaminophen Tablets

Defective Container: Defective bottles may not have tamper evident seals properly seated, and therefore it may be difficult to determine if the product had been opened or tampered with.

Terminated Packaging defect Watson Laboratories Inc NDC 0591-2611-05 D-1061-2013
Class III · Low risk

SPIRIVA HandiHaler

Presence of Foreign Substance: This recall is being conducted due to the potential for extrinsic foreign particles in the API used to manufacture SPIRIVA Handihaler

Terminated Particulate / foreign matter Boehringer Ingelheim Roxane Inc NDC 0597-0075-27 D-1057-2013
Class III · Low risk

buPROPion Hydrochloride Extended-Release Tablets

Failed Dissolution Specifications: This recall is an extension of the recall initiated on 07/31/2013 for Bupropion HCl Extended-Release Tablets (XL) 300 mg, because another lot was shown to have similar failing results for dissolution at the 8-hour timepoint.

Terminated Dissolution failure Actavis South Atlantic LLC NDC 67767-142-30 D-917-2013
Class III · Low risk

Introvale (levonorgestrel and ethinyl estradiol)

Contraceptive tablets out of sequence: Contraceptive tablets out of sequence: Introvale (levonorgestrel and ethinyl estradiol tablets USP 0.15mg/0.03mg) is voluntarily being recalled due to inactive placebo tablets incorrectly placed in Week 9, and active tablets placed in Week 13 on the blister card

Terminated Labeling / mix-up Sandoz Incorporated NDC 0781-5584-36 D-854-2013
Class III · Low risk

Maalox

Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Terminated Labeling / mix-up Novartis Consumer Health D-907-2013
Class III · Low risk

Maalox Extra Strength Antacid

Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Terminated Labeling / mix-up Novartis Consumer Health D-906-2013
Class III · Low risk

Maalox Regular Strength Antacid

Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Terminated Labeling / mix-up Novartis Consumer Health D-903-2013

Recalls by year